Sign In

Login

Password

Forgot Password ? Sign Up

Drugs for Neglected Diseases Initiative (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Drugs for Neglected Diseases Initiative" in German language version.

refsWebsite
Global rank German rank
17dndi.org
low place
low place
13doi.org
2nd place
3rd place
13nih.gov
4th place
7th place
9who.int
195th place
255th place
6zdb-katalog.de
123rd place
6th place
6web.archive.org
1st place
1st place
6redirecter.toolforge.org
33rd place
2nd place
3thelancet.com
2,393rd place
2,660th place
3youtube.com
9th place
9th place
2carlosslim.org
low place
low place
2IABotmemento.invalid
low place
low place
2deadurl.invalid
low place
low place
2mementoweb.org
317th place
14th place
1globalab.wordpress.com
low place
low place
1mmv.org
low place
low place
1nytimes.com
7th place
19th place
1europa.eu
68th place
29th place
1kpkesihatan.com
low place
low place
1dovepress.com
low place
8,392nd place
1paho.org
8,358th place
low place
1sahpra.org.za
low place
low place
1frontiersofknowledgeawards-fbbva.es
low place
low place
1tdg.ch
4,856th place
low place
1fondationannemaurer.ch
low place
low place
1fpa.es
8,139th place
8,646th place

IABotmemento.invalid

carlosslim.org

salud.carlosslim.org

deadurl.invalid

dndi.org

doi.org

  • Lallemant, Marc, Shing Chang, Rachel Cohen, Bernard Pécoul: Pediatric HIV – A Neglected Disease ? In: The New England Journal of Medicine. Band 365, Nr. 7, 18. August 2011, S. 581–583, doi:10.1056/NEJMp1107275, PMID 21848457.
  • Weng, Hong-Bo, Hai-Xia Chen, Ming-Wei Wang: Innovation in neglected tropical disease drug discovery and development. In: Infectious Diseases of Poverty. Band 7, Nr. 1, 18. Juni 2018, ISSN 2049-9957, S. 67, doi:10.1186/s40249-018-0444-1, PMID 29950174, PMC 6022351 (freier Volltext).
  • Bompart François: Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience. In: Malaria Journal. Band 10, 2011, S. 143, doi:10.1186/1475-2875-10-143, PMID 21605364, PMC 3117751 (freier Volltext).
  • Lacaze Catherine: The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership. In: Malaria Journal. Band 10, 2011, S. 142, doi:10.1186/1475-2875-10-142, PMID 21605361, PMC 3128010 (freier Volltext).
  • Musa, Ahmed: Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial. In: PLOS Neglected Tropical Diseases. Band 6, Nr. 6, 19. Juni 2012, S. e1674, doi:10.1371/journal.pntd.0001674, PMID 22724029, PMC 3378617 (freier Volltext).
  • Freitas-Junior Lucio H., Chatelain Eric, Andrade Kim Helena, Siqueira-Neto Jair L.: Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it? In: International Journal for Parasitology: Drugs and Drug Resistance. Band 2, 2012, S. 11–19, doi:10.1016/j.ijpddr.2012.01.003, PMID 24533267, PMC 3862432 (freier Volltext).
  • Shyam Sundar, Prabhat Kumar Sinha, Madhukar Rai, Deepak Kumar Verma, Kumar Nawin, Shanawwaj Alam, Jaya Chakravarty, Michel Vaillant, Neena Verma, Krishna Pandey, Poonam Kumari, Chandra Shekhar Lal, Rakesh Arora, Bhawna Sharma, Sally Ellis, Nathalie Strub-Wourgaft, Manica Balasegaram, Piero Olliaro, Pradeep Das, Farrokh Modabber: Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: An open-label, non-inferiority, randomised controlled trial. In: The Lancet. Band 377, Nr. 9764, 2011, S. 477–86, doi:10.1016/S0140-6736(10)62050-8, PMID 21255828.
  • Rabie, Helena, Paolo Denti, Janice Lee, Mhleli Masango, Ashraf Coovadia, Sandy Pillay, Afaaf Liberty, François Simon, Helen McIlleron: Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study. In: The Lancet HIV. Band 6, Nr. 1, 1. Januar 2019, ISSN 2352-3018, S. e32–e42, doi:10.1016/S2352-3018(18)30293-5, PMID 30529029.
  • Cooke, Graham S., Isabelle Andrieux-Meyer, Tanya L. Applegate, Rifat Atun, Jessica R. Burry, Hugo Cheinquer, Geoff Dusheiko, Jordan J. Feld, Charles Gore, Max G. Griswold, Saeed Hamid: Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. In: The Lancet Gastroenterology & Hepatology. Band 4, Nr. 2, 1. Februar 2019, ISSN 2468-1253, S. 135–184, doi:10.1016/S2468-1253(18)30270-X, PMID 30647010 (englisch, Online).
  • Isabelle Andrieux-Meyer, Soek-Siam Tan, Sombat Thanprasertsuk, Nicolas Salvadori, Caroline Menétrey, François Simon, Tim R. Cressey, Hajjah Rosaida Hj Mohd Said, Muhammad Radzi Abu Hassan, Haniza Omar, Hoi-Poh Tee: Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial. In: The Lancet Gastroenterology & Hepatology. Band 6, Nr. 6, 1. Juni 2021, ISSN 2468-1253, S. 448–458, doi:10.1016/S2468-1253(21)00031-5, PMID 33865507 (englisch, Online).
  • José Angelo Lauletta Lindoso, Carlos Henrique Valente Moreira, Mirella Alves Cunha, Igor Thiago Queiroz: Visceral leishmaniasis and HIV coinfection: current perspectives. In: HIV/AIDS: Research and Palliative Care. Band 10, 15. Oktober 2018, S. 193–201, doi:10.2147/HIV.S143929, PMID 30410407, PMC 6197215 (freier Volltext) – (englisch, Online).
  • Alves, Fabiana, Graeme Bilbe, Séverine Blesson, Vishal Goyal, Séverine Monnerat, Charles Mowbray, Gina Muthoni Ouattara, Bernard Pécoul, Suman Rijal, Joelle Rode, Alexandra Solomos: Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives. In: Clinical Microbiology Reviews. Band 31, Nr. 4, 29. August 2018, ISSN 0893-8512, S. e00048–18, doi:10.1128/CMR.00048-18, PMID 30158301, PMC 6148188 (freier Volltext) – (englisch).
  • Mesu, Victor Kande Betu Ku, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Séverine Blesson, François Simon, Sophie Delhomme, Sonja Bernhard, Willy Kuziena, Jean-Pierre Fina Lubaki, Steven Lumeya Vuvu: Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. In: The Lancet. Band 391, Nr. 10116, 13. Januar 2018, ISSN 0140-6736, S. 144–154, doi:10.1016/S0140-6736(17)32758-7, PMID 29113731 (englisch, Online).

dovepress.com

  • José Angelo Lauletta Lindoso, Carlos Henrique Valente Moreira, Mirella Alves Cunha, Igor Thiago Queiroz: Visceral leishmaniasis and HIV coinfection: current perspectives. In: HIV/AIDS: Research and Palliative Care. Band 10, 15. Oktober 2018, S. 193–201, doi:10.2147/HIV.S143929, PMID 30410407, PMC 6197215 (freier Volltext) – (englisch, Online).

europa.eu

ema.europa.eu

fondationannemaurer.ch

fpa.es

frontiersofknowledgeawards-fbbva.es

globalab.wordpress.com

kpkesihatan.com

mementoweb.org

timetravel.mementoweb.org

mmv.org

nih.gov

ncbi.nlm.nih.gov

  • Lallemant, Marc, Shing Chang, Rachel Cohen, Bernard Pécoul: Pediatric HIV – A Neglected Disease ? In: The New England Journal of Medicine. Band 365, Nr. 7, 18. August 2011, S. 581–583, doi:10.1056/NEJMp1107275, PMID 21848457.
  • Weng, Hong-Bo, Hai-Xia Chen, Ming-Wei Wang: Innovation in neglected tropical disease drug discovery and development. In: Infectious Diseases of Poverty. Band 7, Nr. 1, 18. Juni 2018, ISSN 2049-9957, S. 67, doi:10.1186/s40249-018-0444-1, PMID 29950174, PMC 6022351 (freier Volltext).
  • Bompart François: Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience. In: Malaria Journal. Band 10, 2011, S. 143, doi:10.1186/1475-2875-10-143, PMID 21605364, PMC 3117751 (freier Volltext).
  • Lacaze Catherine: The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership. In: Malaria Journal. Band 10, 2011, S. 142, doi:10.1186/1475-2875-10-142, PMID 21605361, PMC 3128010 (freier Volltext).
  • Musa, Ahmed: Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial. In: PLOS Neglected Tropical Diseases. Band 6, Nr. 6, 19. Juni 2012, S. e1674, doi:10.1371/journal.pntd.0001674, PMID 22724029, PMC 3378617 (freier Volltext).
  • Freitas-Junior Lucio H., Chatelain Eric, Andrade Kim Helena, Siqueira-Neto Jair L.: Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it? In: International Journal for Parasitology: Drugs and Drug Resistance. Band 2, 2012, S. 11–19, doi:10.1016/j.ijpddr.2012.01.003, PMID 24533267, PMC 3862432 (freier Volltext).
  • Shyam Sundar, Prabhat Kumar Sinha, Madhukar Rai, Deepak Kumar Verma, Kumar Nawin, Shanawwaj Alam, Jaya Chakravarty, Michel Vaillant, Neena Verma, Krishna Pandey, Poonam Kumari, Chandra Shekhar Lal, Rakesh Arora, Bhawna Sharma, Sally Ellis, Nathalie Strub-Wourgaft, Manica Balasegaram, Piero Olliaro, Pradeep Das, Farrokh Modabber: Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: An open-label, non-inferiority, randomised controlled trial. In: The Lancet. Band 377, Nr. 9764, 2011, S. 477–86, doi:10.1016/S0140-6736(10)62050-8, PMID 21255828.
  • Rabie, Helena, Paolo Denti, Janice Lee, Mhleli Masango, Ashraf Coovadia, Sandy Pillay, Afaaf Liberty, François Simon, Helen McIlleron: Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study. In: The Lancet HIV. Band 6, Nr. 1, 1. Januar 2019, ISSN 2352-3018, S. e32–e42, doi:10.1016/S2352-3018(18)30293-5, PMID 30529029.
  • Cooke, Graham S., Isabelle Andrieux-Meyer, Tanya L. Applegate, Rifat Atun, Jessica R. Burry, Hugo Cheinquer, Geoff Dusheiko, Jordan J. Feld, Charles Gore, Max G. Griswold, Saeed Hamid: Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. In: The Lancet Gastroenterology & Hepatology. Band 4, Nr. 2, 1. Februar 2019, ISSN 2468-1253, S. 135–184, doi:10.1016/S2468-1253(18)30270-X, PMID 30647010 (englisch, Online).
  • Isabelle Andrieux-Meyer, Soek-Siam Tan, Sombat Thanprasertsuk, Nicolas Salvadori, Caroline Menétrey, François Simon, Tim R. Cressey, Hajjah Rosaida Hj Mohd Said, Muhammad Radzi Abu Hassan, Haniza Omar, Hoi-Poh Tee: Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial. In: The Lancet Gastroenterology & Hepatology. Band 6, Nr. 6, 1. Juni 2021, ISSN 2468-1253, S. 448–458, doi:10.1016/S2468-1253(21)00031-5, PMID 33865507 (englisch, Online).
  • José Angelo Lauletta Lindoso, Carlos Henrique Valente Moreira, Mirella Alves Cunha, Igor Thiago Queiroz: Visceral leishmaniasis and HIV coinfection: current perspectives. In: HIV/AIDS: Research and Palliative Care. Band 10, 15. Oktober 2018, S. 193–201, doi:10.2147/HIV.S143929, PMID 30410407, PMC 6197215 (freier Volltext) – (englisch, Online).
  • Alves, Fabiana, Graeme Bilbe, Séverine Blesson, Vishal Goyal, Séverine Monnerat, Charles Mowbray, Gina Muthoni Ouattara, Bernard Pécoul, Suman Rijal, Joelle Rode, Alexandra Solomos: Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives. In: Clinical Microbiology Reviews. Band 31, Nr. 4, 29. August 2018, ISSN 0893-8512, S. e00048–18, doi:10.1128/CMR.00048-18, PMID 30158301, PMC 6148188 (freier Volltext) – (englisch).
  • Mesu, Victor Kande Betu Ku, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Séverine Blesson, François Simon, Sophie Delhomme, Sonja Bernhard, Willy Kuziena, Jean-Pierre Fina Lubaki, Steven Lumeya Vuvu: Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. In: The Lancet. Band 391, Nr. 10116, 13. Januar 2018, ISSN 0140-6736, S. 144–154, doi:10.1016/S0140-6736(17)32758-7, PMID 29113731 (englisch, Online).

nytimes.com

paho.org

iris.paho.org

  • Pan American Health Organization: Guideline for the Treatment of Leishmaniasis in the Americas. Second Edition. PAHO, 2022, ISBN 978-92-75-12504-5 (englisch, Online).

redirecter.toolforge.org

  • WHO | The World Health Assembly Resolution on the „Control of Leishmaniasis“. 18. Oktober 2014, archiviert vom Original am 18. Oktober 2014; abgerufen am 30. November 2022.
  • Elimination of Kala-azar. World Health Organization, 2012, archiviert vom Original am 10. April 2016; abgerufen am 30. November 2022.
  • DNDi receives FINEP Award. Archiviert vom Original am 12. April 2016; abgerufen am 30. November 2022.
  • Finep Award. Archiviert vom Original am 12. April 2016; abgerufen am 30. November 2022.
  • Prix de l'innovation 2017 CCIG DSE OPI – Bernard Pécoul, DNDi. Archiviert vom Original am 3. Juni 2023; abgerufen am 6. Februar 2020 (englisch).  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/www.youtube.com
  • Strengthening Capacity. Archiviert vom Original (nicht mehr online verfügbar) am 10. Mai 2020; abgerufen am 30. November 2022.  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/www.dndi.org

sahpra.org.za

tdg.ch

thelancet.com

  • Cooke, Graham S., Isabelle Andrieux-Meyer, Tanya L. Applegate, Rifat Atun, Jessica R. Burry, Hugo Cheinquer, Geoff Dusheiko, Jordan J. Feld, Charles Gore, Max G. Griswold, Saeed Hamid: Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. In: The Lancet Gastroenterology & Hepatology. Band 4, Nr. 2, 1. Februar 2019, ISSN 2468-1253, S. 135–184, doi:10.1016/S2468-1253(18)30270-X, PMID 30647010 (englisch, Online).
  • Isabelle Andrieux-Meyer, Soek-Siam Tan, Sombat Thanprasertsuk, Nicolas Salvadori, Caroline Menétrey, François Simon, Tim R. Cressey, Hajjah Rosaida Hj Mohd Said, Muhammad Radzi Abu Hassan, Haniza Omar, Hoi-Poh Tee: Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial. In: The Lancet Gastroenterology & Hepatology. Band 6, Nr. 6, 1. Juni 2021, ISSN 2468-1253, S. 448–458, doi:10.1016/S2468-1253(21)00031-5, PMID 33865507 (englisch, Online).
  • Mesu, Victor Kande Betu Ku, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Séverine Blesson, François Simon, Sophie Delhomme, Sonja Bernhard, Willy Kuziena, Jean-Pierre Fina Lubaki, Steven Lumeya Vuvu: Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. In: The Lancet. Band 391, Nr. 10116, 13. Januar 2018, ISSN 0140-6736, S. 144–154, doi:10.1016/S0140-6736(17)32758-7, PMID 29113731 (englisch, Online).

web.archive.org

  • WHO | The World Health Assembly Resolution on the „Control of Leishmaniasis“. 18. Oktober 2014, archiviert vom Original am 18. Oktober 2014; abgerufen am 30. November 2022.
  • Elimination of Kala-azar. World Health Organization, 2012, archiviert vom Original am 10. April 2016; abgerufen am 30. November 2022.
  • DNDi receives FINEP Award. Archiviert vom Original am 12. April 2016; abgerufen am 30. November 2022.
  • Finep Award. Archiviert vom Original am 12. April 2016; abgerufen am 30. November 2022.
  • Prix de l'innovation 2017 CCIG DSE OPI – Bernard Pécoul, DNDi. Archiviert vom Original am 3. Juni 2023; abgerufen am 6. Februar 2020 (englisch).  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/www.youtube.com
  • Strengthening Capacity. Archiviert vom Original (nicht mehr online verfügbar) am 10. Mai 2020; abgerufen am 30. November 2022.  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/www.dndi.org

who.int

who.int

apps.who.int

youtube.com

zdb-katalog.de

  • Weng, Hong-Bo, Hai-Xia Chen, Ming-Wei Wang: Innovation in neglected tropical disease drug discovery and development. In: Infectious Diseases of Poverty. Band 7, Nr. 1, 18. Juni 2018, ISSN 2049-9957, S. 67, doi:10.1186/s40249-018-0444-1, PMID 29950174, PMC 6022351 (freier Volltext).
  • Rabie, Helena, Paolo Denti, Janice Lee, Mhleli Masango, Ashraf Coovadia, Sandy Pillay, Afaaf Liberty, François Simon, Helen McIlleron: Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study. In: The Lancet HIV. Band 6, Nr. 1, 1. Januar 2019, ISSN 2352-3018, S. e32–e42, doi:10.1016/S2352-3018(18)30293-5, PMID 30529029.
  • Cooke, Graham S., Isabelle Andrieux-Meyer, Tanya L. Applegate, Rifat Atun, Jessica R. Burry, Hugo Cheinquer, Geoff Dusheiko, Jordan J. Feld, Charles Gore, Max G. Griswold, Saeed Hamid: Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. In: The Lancet Gastroenterology & Hepatology. Band 4, Nr. 2, 1. Februar 2019, ISSN 2468-1253, S. 135–184, doi:10.1016/S2468-1253(18)30270-X, PMID 30647010 (englisch, Online).
  • Isabelle Andrieux-Meyer, Soek-Siam Tan, Sombat Thanprasertsuk, Nicolas Salvadori, Caroline Menétrey, François Simon, Tim R. Cressey, Hajjah Rosaida Hj Mohd Said, Muhammad Radzi Abu Hassan, Haniza Omar, Hoi-Poh Tee: Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial. In: The Lancet Gastroenterology & Hepatology. Band 6, Nr. 6, 1. Juni 2021, ISSN 2468-1253, S. 448–458, doi:10.1016/S2468-1253(21)00031-5, PMID 33865507 (englisch, Online).
  • Alves, Fabiana, Graeme Bilbe, Séverine Blesson, Vishal Goyal, Séverine Monnerat, Charles Mowbray, Gina Muthoni Ouattara, Bernard Pécoul, Suman Rijal, Joelle Rode, Alexandra Solomos: Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives. In: Clinical Microbiology Reviews. Band 31, Nr. 4, 29. August 2018, ISSN 0893-8512, S. e00048–18, doi:10.1128/CMR.00048-18, PMID 30158301, PMC 6148188 (freier Volltext) – (englisch).
  • Mesu, Victor Kande Betu Ku, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Séverine Blesson, François Simon, Sophie Delhomme, Sonja Bernhard, Willy Kuziena, Jean-Pierre Fina Lubaki, Steven Lumeya Vuvu: Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. In: The Lancet. Band 391, Nr. 10116, 13. Januar 2018, ISSN 0140-6736, S. 144–154, doi:10.1016/S0140-6736(17)32758-7, PMID 29113731 (englisch, Online).